Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. Ann N Y Acad Sci. 2013 Jul; 1291:1-13.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.